- Home
- BKTI vs TARA Comparison
BKTI vs TARA Comparison
Compare BKTI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKTI | TARA |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | 120 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.1M | 236.1M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BKTI | TARA |
|---|---|---|
| Price | $74.67 | $3.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $74.00 | $24.40 |
| AVG Volume (30 Days) | 30.2K | ★ 740.8K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.89 | 38.25 |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $74,094,000.00 | $2,948,000.00 |
| Revenue This Year | $6.57 | N/A |
| Revenue Next Year | $15.00 | N/A |
| P/E Ratio | $50.93 | ★ N/A |
| Revenue Growth | ★ 45.42 | N/A |
| 52 Week Low | $60.00 | $3.32 |
| 52 Week High | $104.55 | $7.82 |
Technical Indicators
Market Signals| Indicator | BKTI | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 30.77 |
| Support Level | $74.86 | N/A |
| Resistance Level | $79.54 | $4.13 |
| Average True Range (ATR) | 2.23 | 0.20 |
| MACD | 0.54 | -0.04 |
| Stochastic Oscillator | 82.80 | 7.64 |
Price Performance
Historical ComparisonAbout BKTI BK Technologies Corporation
BK Technologies Corp is a holding company that, through BK Technologies, Inc., its operating subsidiary, provides public safety-grade communications products and services designed to make first responders safer and more efficient. All operating activities described herein are undertaken by its operating subsidiary. The Company has one reportable segment - Land Mobile Radio (LMR) Products and Solutions. The LMR segment provides radio devices that are hand-held (portable) or installed in vehicles (mobile) and operate on private radio systems that are P25 compliant. The Company derives revenue in North America and manages the business activities on a consolidated basis.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.